drugset / Trial / NCT03744312
Imaging Inflammation in Alzheimer's Disease With 11C-ER176
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
This study is being done to learn about inflammation in the brain of those with Alzheimer's disease (AD). The purpose of this study is to determine if 11C-ER176 is able to accurately measure inflammation in patients with Alzheimer's disease. Both patients (with either mild cognitive impairment (MCI) or Alzheimer's disease) and healthy controls (participants without memory complaints or impairment) will be included in this study.
Timeline
- Start
- 2018-09-10
- Primary completion
- 2022-07-20
- Completion
- 2022-07-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 11C-ER176 | Diagnostic / imaging agent | — | Other |
| Subject | Florbetaben | Diagnostic / imaging agent | — | Other |